Morphic to present at the jefferies global healthcare conference

Waltham, mass., june 06, 2023 (globe newswire) -- morphic therapeutic (nasdaq: morf), a biopharmaceutical company developing a new generation of oral integrin therapies for the treatment of serious chronic diseases, today announced that its management team will participate in the jefferies healthcare conference, including a hosted fireside chat, on wednesday, june 7, 2023.
MORF Ratings Summary
MORF Quant Ranking